tirzepatide semaglutide blend Compounded Program: Results, Timeline & Comparison Tirzepatide vs Semaglutide: Weight Loss

It takes just a few minutes to complete some questions about your medical history

Meet our experts Gillian Goddard , MD, a board-certified endocrinologist, adjunct assistant professor of medicine at NYU Grossman School of Medicine and author of The Hormone Loop Edwin Davila , DO, internal medicine physician, scientific advisory board member at the National Academy of Sports Medicine Anath Shalev , MD, director of the University of Alabama at Birmingham Comprehensive Diabetes Center Thomas Rutledge , PhD, staff psychologist at the VA San Diego Healthcare System, professor of psychiatry at UC San Diego Our health content is for informational purposes only and is not intended as professional medical advice

Matched cohorts were followed for 12 months after the index event

Even though semaglutide is the active drug in both cases, Wegovy is not approved to treat patients with type 2 diabetes

It does so by stimulating insulin release and reducing glucagon, among other actions